Search Within

Mikhail Roshal

Formats
  1. Meeting Abstract (111)
  2. Journal Article (86)
  3. Book Section (15)
  4. Research Letter (12)
  5. Review (9)
  6. Correspondence (1)
  7. Editorial (1)
  8. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (236)
  2. Center for Hematologic Malignancies (154)
  3. Department of Medicine (146)
  4. Hematologic Malignancies, Division of (146)
  5. Adult Leukemia (99)
  6. Sloan Kettering Institute Postdocs (77)

More Groups

People
  1. Ahmet Dogan (98)
  2. Maria Arcila (68)
  3. Qi Gao (67)
  4. Wenbin Xiao (64)
  5. Yanming Zhang (58)
  6. Sergio Giralt (40)

More People

Years
  1. 2025 (13)
  2. 2024 (11)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (26)

More Years

Publications
  1. Blood (65)
  2. Laboratory Investigation (23)
  3. Modern Pathology (18)
  4. Blood Advances (15)
  5. Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. 3rd ed (14)
  6. Cytometry Part B—Clinical Cytometry (9)

More Publications

Publishers
  1. American Society of Hematology (80)
  2. Nature Publishing Group (29)
  3. Elsevier Inc. (24)
  4. Nature Research (19)
  5. Wiley Blackwell (15)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (236)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chemotherapy-related mutational signatures reveal the origins of therapy-related myeloid neoplasms
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Boyle, E. M.; Maclachlan, K.; Taylor, J.; Watts, J. M.; Lu, S. X.; Coffey, D. G.; Bolli, N.; Papaemmanuil, E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials
    Meeting Abstract

    Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Chemotherapy signatures reveal the evolutionary history of post-melphalan myeloid neoplasm
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Coffey, D.; Lu, S.; Bolli, N.; Bolton, K.; Park, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Immune escape after allogeneic hematopoietic cell transplantation in pediatric patients with acute myeloid leukemia
    Meeting Abstract

    Shahid, S.; Ceglia, N.; Le Luduec, J. B.; McPherson, A.; Spitzer, B.; Bojilova, V.; Panjwani, M. K.; Roshal, M.; Shah, S.; Abdel-Wahab, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Erythroid and megakaryocytic differentiation program in JAK2-mutated acute myeloid leukemia with or without antecedent myeloproliferative neoplasm
    Meeting Abstract

    Liu, Y.; Sethi, S.; Koche, R.; Gao, Q.; Dilip, D.; Glass, J. L.; Galera, P. K.; Persaud, S.; Mishra, T.; Sun, X.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • High-resolution single cell T-cell phenotyping of B-cell lineage lymphomas reveals unique immune signatures and potential targetable vulnerabilities
    Meeting Abstract

    El Daker, S.; Baik, J.; Dogan, A.; Zhu, M.; Roshal, M.; Galera, P. K.
    Blood (2022)

    Fulltext@MSK | Save
  • Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia
    Meeting Abstract

    Robinson, T.; Bowman, R. L.; Persaud, S.; Liu, Y.; Gao, Q.; Zhang, J. P.; Sun, X.; Sciambi, A.; Llanso, A.; Famulare, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Meeting Abstract

    Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Stem cell autograft minimal residual disease negativity improves outcomes after autotransplant for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Hultcrantz, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save